The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 70, Issue 18, 2007, Pages 1556-1567

  Kassa, Jiri ^a,b   Karasova, Jana ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 1,4 BIS(4 HYDROXYIMINOMETHYLPYRIDINIUM)BUT 2 EN DIBROMIDE; ANTIDOTE; ATROPINE; BIS(PYRIDINIUM OXIME) DERIVATIVE; K 075; OBIDOXIME; TABUN; TRIMEDOXIME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GAS POISONING; LD 50; MALE; MOTOR ACTIVITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OBSERVATIONAL METHOD; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SURVIVAL TIME;

ANIMALS; ATROPINE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; DRUG THERAPY, COMBINATION; MUSCARINIC ANTAGONISTS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; OXIMES; PHOSPHORIC ACID ESTERS; RATS; RATS, WISTAR;

RATTUS;

EID: 34548132022     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390701384775     Document Type: Article

References (36)

1. Bajgar, J. 2006. The usage of chemical weapons and chemical weapons conventions: From history to the present (in Czech). Hradec Kralove: Nukleus.
2. Cabal, J., and Bajgar, J. 1999. Tabun - Reappearance 50 years later (in Czech). Chem. Listy 93:27-31.
3. Cabal, J., Kuca, K., and Kassa, J. 2004. Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Pharmacol. Toxicol. 95:81-86.
4. Cassel, G., Karlsson, L., Waara, L., Wee Ang, K., and Goransson-Nyberg, A. 1997 Pharmacokinetics and effects of HI-6 in blood and brain of somanintoxicated rats: A microdialysis study. Eur. J. Pharmacol. 332:43-52.
5. Dawson, R. M. 1994. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 14:317-331.
6. Dohnal,V., Kuca, K., and Jun, D. 2005. Prediction of a new broad-spectrum reactivator capable of reactivating acetylcholinesterase inhibited by nerve agents. J. Appl. Toxicol. 3:139-145.
7. Eto, M. 1976. Organophosphorus pesticides. In Organic and biological chemistry, pp. 142-143. Cleveland, OH: CRC Press.
8. Frantik, E., and Hornychova, M. 1995. Clustering of neurobehavioral measures of toxicity. Homeostasis 36:19-25.
9. Hornychova, M., Frantik, E., Kubat, J., and Formanek, J. 1995. Neurotoxicity profile of supermethrin, a new pyrethroid insecticide. Central Eur. J. Public Health 3:210-218.
10. Jokanovic, M. 1993. Anticholinesterase activity and delayed neurotoxic effects of tabun in hens. Vojvosanit. Pregl. 50:451-456.
11. Jokanovic, M., Maksimovic, M., Kilibarda, V., Jovanovic, D., and Savic, D. 1996. Oxime-induced reactivation of acetycholinesterase inhibited by phosphoramidates. Toxicol. Lett. 85:35-39.
12. Kassa, J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 40:803-816.
13. Kassa, J., and Cabal, J. 1999a. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111-118.
14. Kassa, J., and Cabal, J. 1999b. A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol. Toxicol. 84:41-45.
15. Kassa, J., Cabal, J., and Kuca, K. 2005. A comparison of the efficacy of currently available oximes against tabun in rats. Biologia 60(suppl. 17):77-79.
16. Kassa, J., and Koupilova, M. 2000. The importance of anticholinergic drug selection for the neuroprotective effects of antidotes in soman-poisoned rats. Homeostasis 1-2:52-53.
17. Kassa, J., and Krejcova, G. 2003. Neuroprotective effects of currently used antidotes in tabun-poisoned rats. Pharmacol. Toxicol. 92:258-264.
18. Kassa, J., Kuca, K., Cabal, J., and Paar, M. 2006. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. J. Toxicol. Environ. Health A 69:1875-1882.
19. Kassa, J., and Kunesova, G. 2006a. Comparison of the neuroprotective effects of the newly developed oximes (K027, K048) with trimedoxime in tabun-poisoned rats. J. Appl. Biomed. 4:123-134.
20. Kassa, J., and Kunesova, G. 2006b. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. J. Appl. Toxicol. 26:309-316.
21. Kuca, K., Cabal, J., Musilek, K., Jun, D., and Bajgar, J. 2005a. Effective bisquaternary reactivators of tabun-inhibited AChE. J. Appl Toxicol. 25:491-495.
22. Kuca, K., Cabal, J., Jun, D., Kassa, J., Bartosova, L., and Kunesova, G. 2005b. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions. J. Appl. Toxicol. 25:296-300.
23. Kuca, K., Cabal, J., Kassa, J., Jun, D., and Hrabinova, M. 2006. In vitro potency of H oximes (HI-6, Hlo-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat bran acetylcholinesterase. J. Toxicol. Environ. Health A 69:1431-1440.
24. Marrs, T.C. 1993. Organophosphate poisoning. Pharmacol. Ther. 58:51-66.
25. McDonough, J. H., Jr., Zoeffel, L. D., McMonagle, J., Copeland, T. L., Smith, C. D., and Shih, T.-M. 2000. Anticonvulsant treatment of nerve agent seizures: Anticholinergics versus diazepam in soman-intoxicated guinea-pigs. Epilepsy Res. 38:1-14.
26. Moser, V. C., Tilson, H., McPhail, R. C., Becking, G. C., Cuomo, V., Frantik, E., Kulig, B. M., and Winneke, G. 1997. The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. Neurotoxicology 18:929-938.
27. Ohtomi, S., Takase, M., and Kumagai, F. 1996. Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int. Rev. Arm. Serv. 69:97-102.
28. Pang, Y. P., Kollmeyer, T. M., Hong, F., Lee, J. C., Hammond, P. I., Haugabouk, S. P., and Brimijoin, S. 2003. Rational design of alkylene-linked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators. Chem. Biol. 10:491-502.
29. Patocka, J., Bielavsky, J., and Ornst, F. 1970. Reactivating effect of αω-bis-(4-pyridinealdoxime)-2-trans-butene dibromide on isopropyl-methylphosphonylated acetylcholinesterase. FEBS Lett. 10:182-184.
30. Patocka, J., Cabal, J., Kuca, K., and Jun, D. 2005. Oxime reactivation of acetylcholinesterase inhibited by toxic phosphorus esters: In vitro kinetics and thermodynamics. J. Appl. Biomed. 3:91-99.
31. Poziomek, E. J., Hackley, B. E., and Steinberg, G. M. 1958. Pyridinium aldoximes. J. Org. Chem. 23:714-717.
32. Puu, G., Artursson, E., and Bucht, G. 1986. Reactivation of nerve agent inhibited acetylcholinesterase by HI-6 and obidoxime. Biochem. Pharmacol. 35:1505-1510.
33. Roth, Z., Josifko, M., Maly, V., and Trcka, V. 1962. Statistical methods in experimental medicine (in Czech). Prague: SZN.
34. Sakurada, K., Matsubara, K., Shimizu, K., Shiono, H., Seto, Y., Tsuge, K., Toshibo, M., Sakai, I., Mukoyama, H., and Takatori, T. 2003. Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem. Res. 28:1401-1407.
35. Taylor, P. 1996. Anticholinesterase agents. In: The pharmacological basis of therapeutics, eds. J. G. Hardman and L. E. Limbird, pp. 161-176. NewYork: McGraw-Hill.
36. Worek, F., Widmann, R., Knopff, O., and Szinicz, L. 1998. Reactivating potency of obidoxime, pralidoxime, HI-6 and HLö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch. Toxicol. 72:237-243.